Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice

被引:124
作者
Kang, SY
Lee, KY
Park, MJ
Kim, YC
Markelonis, GJ
Oh, TH
Kim, YC
机构
[1] Seoul Natl Univ, Coll Pharm, Kwanak Gu, Seoul 151742, South Korea
[2] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA
关键词
Angelica gigas; anti-amnestic compounds; decursin; decursinol; AChE inhibition; passive avoidance test; Morris water maze test;
D O I
10.1016/S1074-7427(02)00007-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
We previously reported that a total methanolic extract of the underground part of Angelica gigas Nakai (Umbelliferae) (hereinafter abbreviated AG) significantly inhibited acetyleholinesterase (AChE) activity. We characterized 12 coumarin derivatives including both decursin and decursinol from extracts of AG. In this study, we evaluated the anti-amnestic activity of decursin, a major coumarin constituent isolated from AG, in vivo using ICR mice with amnesia induced by scopolamine (1 mg/kg body weight, s.c.). Decursin, when administered to mice at 1 and 5 mg/kg body weight i.p., significantly ameliorated scopolamine-induced amnesia as measured in both the passive avoidance test and the Morris water maze test. Moreover, decursin significantly inhibited AChE activity by 34% in the hippocampus of treated mice. These results indicate that decursin may exert anti-amnestic activity in vivo through inhibition of AChE activity in the hippocampus. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 39 条
[1]   Decursin: A cytotoxic agent and protein kinase C activator from the root of Angelica gigas [J].
Ahn, KS ;
Sim, WS ;
Kim, IH .
PLANTA MEDICA, 1996, 62 (01) :7-9
[2]  
[Anonymous], PHARMACOGNOSY
[3]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[4]   PATTERNS OF MEMORY FAILURE AFTER SCOPOLAMINE TREATMENT - IMPLICATIONS FOR CHOLINERGIC HYPOTHESES OF DEMENTIA [J].
BEATTY, WW ;
BUTTERS, N ;
JANOWSKY, DS .
BEHAVIORAL AND NEURAL BIOLOGY, 1986, 45 (02) :196-211
[5]   Effect of rivastigmine on scopolamine-induced memory impairment in rats [J].
Bejar, C ;
Wang, RH ;
Weinstock, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) :231-240
[6]   Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? [J].
Benzi, G ;
Moretti, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) :1-13
[7]   An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: Comparison with other cholinesterase inhibitors [J].
Braida, D ;
Paladini, E ;
Griffini, P ;
Lamperti, M ;
Maggi, A ;
Sala, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 302 (1-3) :13-20
[8]  
BUCHNELL PJ, 1990, BEHAV PHARMACOL, V1, P419
[9]   Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities [J].
Cheng, DH ;
Tang, XC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (02) :377-386
[10]   CHOLINERGIC BLOCKADE AS A MODEL OF THE COGNITIVE DEFICITS IN ALZHEIMERS-DISEASE [J].
CHRISTENSEN, H ;
MALTBY, N ;
JORM, AF ;
CREASEY, H ;
BROE, GA .
BRAIN, 1992, 115 :1681-1699